作者
Karin Dahlman-Wright, Vincent Cavailles, Suzanne A Fuqua, V Craig Jordan, John A Katzenellenbogen, Kenneth S Korach, Adriana Maggi, Masami Muramatsu, Malcolm G Parker, Jan-Åke Gustafsson
发表日期
2006/12/1
来源
Pharmacological reviews
卷号
58
期号
4
页码范围
773-781
出版商
American Society for Pharmacology and Experimental Therapeutics
简介
Estrogen receptors (ERs1) are ligand-activated transcription factors that belong to the nuclear hormone receptor superfamily. In the late 1950s, the existence of a receptor molecule that could bind 17ß-estradiol was demonstrated by Jensen and Jacobsen (Jensen and Jordan, 2003). The first ER was cloned in 1986 (Green et al., 1986; Greene et al., 1986). This receptor was regarded as the only ER until a second ER was reported in 1996 (Kuiper et al., 1996). The two receptors are today known as ERɑ and ERß, respectively. ERɑ and ERß show a high degree of similarity when compared at the amino acid level. The amino acid sequence identity between ERɑ and ERß is approximately 97% in the DNA-binding domain and approximately 56% in the ligand-binding domain (LBD), whereas the N terminus is poorly homologous at 24%. Transcriptional activation by ERɑ is mediated by two distinct activation functions …
引用总数
200720082009201020112012201320142015201620172018201920202021202220232024163357545454566052564244494947403211
学术搜索中的文章
K Dahlman-Wright, V Cavailles, SA Fuqua, VC Jordan… - Pharmacological reviews, 2006